Free Trial
NYSE:NEUE

NeueHealth (NEUE) Stock Price, News & Analysis

NeueHealth logo
$6.85 -0.09 (-1.30%)
Closing price 03:59 PM Eastern
Extended Trading
$6.83 -0.02 (-0.29%)
As of 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About NeueHealth Stock (NYSE:NEUE)

Key Stats

Today's Range
$6.78
$6.86
50-Day Range
$4.71
$7.45
52-Week Range
$3.79
$7.66
Volume
18,270 shs
Average Volume
19,842 shs
Market Capitalization
$56.75 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.00
Consensus Rating
Hold

Company Overview

NeueHealth, Inc., a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics. It operates risk-bearing clinics under the Centrum Health, AssociatesMD, and Premier Medical Associates brand names. The company also offers integrated system care solution, such as embedded pharmacy, laboratory, radiology, and population health focused specialty services; and chronic care management, transitions of care, and referral management services. The NeueSolutions segment enables providers and medical groups to succeed in performance-based arrangements; and participates in the centers for healthcare access to medicare beneficiaries. The company was formerly known as Bright Health Group, Inc. and changed its name to NeueHealth, Inc. in January 2024. NeueHealth, Inc. was incorporated in 2015 and is headquartered in Doral, Florida.

Remove Ads

NeueHealth Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
20th Percentile Overall Score

NEUE MarketRank™: 

NeueHealth scored higher than 20% of companies evaluated by MarketBeat, and ranked 869th out of 941 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    NeueHealth has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    NeueHealth has received no research coverage in the past 90 days.

  • Read more about NeueHealth's stock forecast and price target.
  • Earnings Growth

    Earnings for NeueHealth are expected to grow in the coming year, from ($9.13) to ($9.01) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of NeueHealth is -0.13, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of NeueHealth is -0.13, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about NeueHealth's valuation and earnings.
  • Percentage of Shares Shorted

    0.45% of the float of NeueHealth has been sold short.
  • Short Interest Ratio / Days to Cover

    NeueHealth has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in NeueHealth has recently increased by 33.70%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    NeueHealth does not currently pay a dividend.

  • Dividend Growth

    NeueHealth does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.45% of the float of NeueHealth has been sold short.
  • Short Interest Ratio / Days to Cover

    NeueHealth has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in NeueHealth has recently increased by 33.70%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    NeueHealth has a news sentiment score of -0.13. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.78 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for NeueHealth this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, NeueHealth insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $774,560.00 in company stock.

  • Percentage Held by Insiders

    64.30% of the stock of NeueHealth is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    63.88% of the stock of NeueHealth is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about NeueHealth's insider trading history.
Receive NEUE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NeueHealth and its competitors with MarketBeat's FREE daily newsletter.

NEUE Stock News Headlines

Trump’s Great Society
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
Q4 2024 NeueHealth Inc Earnings Call
NeueHealth: Q4 Earnings Snapshot
See More Headlines

NEUE Stock Analysis - Frequently Asked Questions

NeueHealth's stock was trading at $7.42 at the beginning of 2025. Since then, NEUE stock has decreased by 7.7% and is now trading at $6.85.
View the best growth stocks for 2025 here
.

NeueHealth, Inc. (NYSE:NEUE) posted its quarterly earnings data on Thursday, March, 20th. The company reported ($7.41) earnings per share (EPS) for the quarter, missing the consensus estimate of ($2.29) by $5.12. The business earned $232.64 million during the quarter, compared to analyst estimates of $261.80 million. NeueHealth had a negative net margin of 36.28% and a negative trailing twelve-month return on equity of 6.40%.

NeueHealth's top institutional shareholders include Renaissance Technologies LLC (0.68%), Northern Trust Corp (0.39%), Virtu Financial LLC (0.12%) and Concourse Financial Group Securities Inc.. Insiders that own company stock include Jay Matushak, Tomas Orozco, Jeffery Michael Craig and Jeffrey J Scherman.
View institutional ownership trends
.

Shares of NEUE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that NeueHealth investors own include Jiuzi (JZXN), ARMOUR Residential REIT (ARR), Aethlon Medical (AEMD), Aditxt (ADTX), Ainos (AIMD), Adial Pharmaceuticals (ADIL) and Avalon GloboCare (ALBT).

Company Calendar

Last Earnings
3/20/2025
Today
3/28/2025
Next Earnings (Estimated)
5/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Hospital & medical service plans
Sub-Industry
Insurance
Current Symbol
NYSE:NEUE
Previous Symbol
NYSE:NEUE
Fax
N/A
Employees
1,252
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$7.00
High Stock Price Target
$7.00
Low Stock Price Target
$7.00
Potential Upside/Downside
+2.2%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-1,151,450,000.00
Pretax Margin
-11.79%

Debt

Sales & Book Value

Annual Sales
$936.66 million
Cash Flow
$57.08 per share
Price / Cash Flow
0.12
Book Value
($158.35) per share
Price / Book
-0.04

Miscellaneous

Free Float
2,958,000
Market Cap
$56.75 million
Optionable
N/A
Beta
0.56
Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report

This page (NYSE:NEUE) was last updated on 3/28/2025 by MarketBeat.com Staff
From Our Partners